Public Health · Vol. 11, No. 1 · 2026 · pp. 584–589 · e-ISSN 2472-3878

Quality of Life and Surgical Outcome After Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy for Benign Disease: A Randomized Controlled Trial

Chaitra R P, Mahendra G, Shruti K K, Yanamadala Lijaswi

Professor and HOD, Department of OBG, Adichunchanagiri Institute of Medical Sciences, B.G. Nagara, Karnataka, IndiaIndia
Senior Resident, Department of OBG, Adichunchanagiri Institute of Medical Sciences, B.G. Nagara, Karnataka, IndiaIndia

DOI: https://doi.org/10.17140/phoj-11-584 · Published 2026-07-18 · Received 2026-03-13 · Revised 2026-04-15 · Accepted 2026-05-11 · Licence: https://creativecommons.org/licenses/by/4.0 · © 2026 The Author(s)

Abstract

Hysterectomy is a widely performed surgical procedure for benign gynecological conditions such as uterine fibroids, abnormal uterine bleeding, and endometriosis. This randomized controlled trial compares total laparoscopic hysterectomy (TLH) and total abdominal hysterectomy (TAH) in terms of surgical outcomes and quality of life (QoL). Sixty participants were randomized into two groups: TLH (n=30) and TAH (n=30). TLH demonstrated reduced blood loss, shorter hospital stays, and higher QoL scores on the RAND-36 questionnaire compared to TAH, despite longer operating times. These findings reinforce TLH as the preferred approach for managing benign gynecological conditions.

Keywords: TAH; TLH; Quality of life; Surgical outcome; RAND-36; Qualityoflife; Surgicaloutcome

Introduction

Hysterectomy,thesurgicalremovalofuterusisoneof thegynaecologicaloperationsperformedduetobenignindicationssuchasuterineleiomyoma,abnormal uterinebleeding,endometrialhyperplasia,dysmenorrhea,dyspareunia,andsevereendometriosisrefractorytomedicalorconservativesurgicalmanagement orincasesofrejectionbythepatient[1].Manysymptomsthatemergepriortohysterectomysuchasheavy andprolongedmenstrualbleeding,chronicpelvicpain, dyspareunia,anddysmenorrheanegativelyaffectthe qualityoflife.Itcanbeexpectedthatahysterectomy madetorelievethesesymptomscanalsoshowpositiveeffectsonpatient’squalityoflife[2]. Theroute ofhysterectomydependsonthepathology,sizeand descentoftheuterus,presenceofendometriosis,the likelihoodofadhesions,previouspelvicsurgery,surgeon’spreference,andpatient’schoice[3].

Totallaparoscopichysterectomyisaminimallyinvasive surgerythataimstoachievesimilarclinicaleffectivenesswithaquickerrecoverythantraditionalabdominalhysterectomy.Becauseoflowercomplicationsand lowerpostoperativepain,lessbloodloss,shorterhospitalizationperiod,shorterhealingtimeandearlyreturnofdailyactivities,laparoscopichysterectomyhas moreadvantagesthanabdominalhysterectomy[4].Laparoscopichysterectomyinvolveslesstissuetrauma andlessinflammatoryresponseduringsurgerywhich resultsinlesspostoperativepainandshorterhealing period. Thedisadvantagesoflaparoscopichysterectomyincludeinjuriestotheurinarytractandlonger operationtime[5]. Butthesetwocomplicationscan bereducedwithimprovementofsurgeon’sskillsand wideruseoflaparoscopicapproachofhysterectomy[6]. Laparoscopichysterectomieshavebeendividedinto threetypes: LAVH(laparoscopicallyassistedvaginal hysterectomy),LH(laparoscopichysterectomy),and TLH(totallaparoscopichysterectomy)[7].TLHinvolves theproceduredonecompletelybylaparoscopewithoutthevaginalcomponentexceptfortheremovalof the uterus by the vaginal route. Although the operatingtimerequiredforlaparoscopichysterectomyis long,theproportionoflaparoscopichysterectomyhas graduallyincreased.Themainadvantagesarethepossibilityofdiagnosingandtreatingotherpelvicdiseases suchasendometriosis,ofcarryingoutadnexalsurgery includingtheremovaloftheovaries,theabilitytosecurethoroughintraperitonealhaemostasis(directlaparoscopicvisionenablescarefulsealingofbleeding vesselsattheendoftheprocedure),andamorerapid recoverytimefromsurgerycomparedtoabdominal hysterectomy[8].

TAH(totalabdominalhysterectomy)isanaccepted,effective,andeasilyperformedprocedureandamore invasiveprocedurethanlaparoscopichysterectomy[9]. Thetraditionalapproachofabdominalhysterectomy isinevitableinmanysituations[10-12].Moreover,gynaecologistsareprimarilytrainedthroughtheabdominalroutecomparedtovaginalandlaparoscopictechniques[13]. Abdominalapproachisassociatedwith anincreasedlengthofhospitalstay,lessrapidreturn tonormalactivities,andmarkedincreaseinsurgical siteinfectionrates.Therefore,theabdominalroutefor hysterectomyisbestreservedforsituationsinwhich minimallyinvasiveapproachesarenotreasonable.Althoughabdominalhysterectomycontinuestobethe mostcommonapproachusedworldwide,thereisgood evidencefrommultiplerandomized,prospectivetrials thatvaginalandlaparoscopichysterectomiesareassociatedwithfewercomplications,ashorterhospitalstay, amorerapidrecovery,andloweroverallcosts. Most patientswithgynaecologicmalignancyarestilloperatedonwithanabdominalincision. Auteruslarger than12weeks’gestationalsizeisareasonablesizeto qualifyforanabdominalapproach.Theshapeandsize ofthepelvicoutletarealsokeyfactors[14].

Thisstudyisaimedatevaluatingthesurgicaleffects, bothshort-termandlong-termeffectsinwomenwho underwentTLHandTAHduetobenignindicationsand qualityoflifepost-surgery.Thereareveryfewstudies comparingthequalityoflifeafterTLHvsTAH.Therefore,themainfocusofthisstudyistoevaluatehow andatwhatperiodoftime, thepatientexperiences the benefits of the surgery after being suffered due toanybenigngynaecologicalconditionsthataffected theirlife(bothphysicalandpsychological)andtoevaluatetheoutcomesofthesurgeryperformedtorelieve womenoftheirdisease.

MaterialsandMethods

StudyDesignandParticipants

This randomized controlled trial was conducted at AdichunchanagiriHospitalandResearchCenterfrom September2022toMay2024.Sixtywomenaged30–60 years,diagnosedwithbenigngynecologicalconditions, wererecruited.Participantswererandomizedintotwo groups:TLH(n=30)andTAH(n=30).

Inclusioncriteria:

1. Womenwithbenigngynaecologicalconditions suchasabnormaluterinebleedingwithleiomyoma,adenomyosis,endometriosis,endometrial polyp,endometrialhyperplasia,benignovarian tumour.

2. Womenabove40yearsofage.

3. Womenwhohavecompletedafamily.

4. Womenwhohavetakenmedicaltreatmentand havenotbeenrelievedofsymptoms.

Exclusioncriteria:

1. Suspicion of malignancy – endometrial carcinoma,cervicalcarcinoma,ovariancarcinoma. 2. Women with uterovaginal prolapse requiring pelvicfloorrepair/vaginalhysterectomy.

3. Womenwhorefusetoanswerqualityoflifequestionnaireswillbeexcludedfromthestudy.

Procedure

StudywascarriedoutindepartmentofOBG,AdichunchanagiriHospitalandResearchCentre,BGNagar.Institutionalethicalcommitteeclearancewasobtained priortobeginstudy. Purposeofstudyandinterventionsareclearlyexplainedtoallparticipantsintheirunderstandablelanguage.Consentedparticipantsfulfillinginclusioncriteriaarerecruitedfrominpatientwards ofgynaecologydepartment. Participantswithexclusionfactorsareexcludedfromstudy.Sameprocedure followedtillcompleterecruitmentofallparticipants. Participants’detailedhistorywiththefollowing:name, age,education,socio-economicstatus,occupation,address,marriedlife,pastmedicalandsurgicalhistory, familyhistory.Generalphysicalexamination,systemic examination,gynaecologyexaminationisdone. Participantsarerandomisedintointerventionorcontrol armbycomputergeneratedrandomnumber. Block randomizationwithblocksizeof5donetomaintain equalparticipantsinbothgroups. Allocationisconcealedbyusingsequentiallynumberedopaquesealed envelopes(infourseparatesets)thatcontaingroup assignmentsdeterminedbycomputer-generatedrandomsequences.Principalinvestigatorgivesthesealed envelopetothehealthcareworkerwhoisintended tocarryoutintervention.Beforesurgery,patientsunderwentroutineexaminations,bloodtests,gynaecologicalexamination,gynaecologicalultrasoundscanning,papsmearandendometrialbiopsy.Patientsreceived antibiotic prophylaxis. All patients were routinelycatheterizedatthebeginningofoperation.Both TLHandTAHwereperformedundergeneralanaesthesia.

DataCollection

Preoperative assessments included medical history, physicalexamination,andimagingstudies.Postoperativeevaluationsfocusedonsurgicaloutcomessuchas bloodloss,operatingtime,andhospitalstay.Quality oflifewasassessedsixweekspostoperativelyusingthe RAND-36questionnaire,avalidatedtoolthatmeasures physical,emotional,andsocialfunctioning.

StatisticalAnalysis

Theentiredatawillbevalidatedbycheckingforand correctinganyunusualvaluesandtypographicerrors. Allthequantitativevariableswillbecheckedforcompliance with normal distribution, within each study groupbyusingvisualinspectionofhistogramsandnormalityQ-Qplots.SkewnessandKurtosisZ-valuesand Shapiro-WilktestP-valueswillalsobeusedforthispurpose.Themeanandstandarddeviationofthenormally distributedquantitativevariableswillbecomparedbetweenthetwogroupsusingindependentsamplet-test. ThemedianandInterQuartileRange(IQR)ofthenonnormallydistributedquantitativevariableswillbecomparedbetweenthetwogroups,usingMann-Whitney Utest.ThequalitativevariableswillbecomparedbetweenthetwomethodsusingChi-squaretest/Fisher’s exacttest.

Table 1. Distributionofparticipantsbasedon co-morbidities

Co-morbidities TLH TAH Total

24 18 42 Nil 80.0% 60.0% 70.0% 0 3 3 DM 0.0% 10.0% 5.0% 3 3 6 HTN 10.0% 10.0% 10.0% 2 3 5 Hypothyroidism 6.7% 10.0% 8.3% 1 3 4 Others 3.3% 10.0% 6.7% 30 30 60 Total 100.0% 100.0% 100.0% Chi-squaretest–5.2withPvalue–0.12

Table 2. Distributionofparticipantsbasedon diagnosis

Diagnosis TLH TAH Total

15 19 34 Fibroid 51.7% 65.5% 58.6% 11 9 20 Adenomyosis 37.9% 31.0% 34.5% 3 1 4 Other 10.3% 3.4% 6.9% 29 29 58 Total 100.0% 100.0% 100.0% Chi-squaretest–1.2withPvalue–0.54

Results

Theanalysisrevealedsignificantdifferencesinsurgical outcomesandqualityoflifebetweentheTLHandTAH groups.

Thekeyfindingswereasfollows: ofbloodlossduringsurgery

AmountofBlood TLH TAH Total lossduringSurgery

23 1 24 <200ml 82.1% 3.3% 41.4% 200–400ml 17.9% 33.3% 25.9% >500ml 0.0% 63.3% 32.8% 28 30 58 Total 100.0% 100.0% 100.0% Chi-squaretest–40.8withPvalue– <0.00001

Table 4. Distributionofparticipantsbasedonduration ofsurgery

Meanduration Std. ∗ P Group Fvalue ofsurgery Deviation Value

TLH 144.17 48.6 TAH 113.67 18.7 ∗ ∗IndependentTtest

1. BloodlossinTLHislesscomparedtoTAH.82.1% ofpatientswhounderwentTLHhadlessthan200 mlbloodloss.Thedifferencebetweenthetwo groupswassignificantwithPvalue <0.00001. 2. The operating time was longer in TLH than in TAH.MeandurationofsurgeryamongTLHwas 144.17minutes.Pvalueis0.001.

3. The TLH group’s mean RAND 36 score was 15.5±8.83,whiletheTAHgroup’swas14.3±7.74.

Discussion

BloodLossDuringSurgery

Incurrentstudymostoftheparticipants(63.3%)inTAH grouphadbloodlossofmorethan500ml,whereas in TLH group blood loss was significantly lower (P <0.002).InastudydonebyAgarwalPetal.,average intraoperativebloodlosswassignificantlylowerinTLH asopposedtoTAH.Similarresultswerealsoobserved byBaeketal.[15]andSutasanasuang[16].Inastudy donebyShakuntla,etal.[17],meanbloodlossintheir study was (35.21±19.61 ml) for the TLH group, this becauseofadventofelectrocoagulationsystem,comparedto(138.4±58.6ml)fortheTAHgroup,anditwas statisticallysignificant.

RAND36Score:PrimaryOutcome

IncurrentstudymeanscoreofRAND36scoreamong ± TLH group was 15.5 8.83 and among TAH group ± was14.3 7.74.Differenceobservedbetweengroups amongrolelimitationsduetoemotionalproblems,energy/fatigue,andpainwerefoundtobestatisticallysignificant.InastudydonebyShakuntla,etal.[12],mean painscoreinTLHwas(2.56±0.97)andthemedianpain scorewas2witharangeof1–5,andinTAHgroupmean painscorewas(5.31±1.02)andthemedianpainscore was5witharangeof4–8.Thisdifferencewasfoundto bestatisticallysignificant,i.e.,themedianpainscore 5 10 15 wassignificantlylessinTLHgroupascomparedtoTAH group.

0 19 19

Complications

Incurrentstudy,complicationsobservedamongTAH group:uretericinjurywasseeninoneparticipant,rectussheathhematomainoneparticipant,andfiveparticipantshadfeverandtwohadwoundgapingneedingsecondarysuturing.InTLHgrouponeparticipant hadbladderinjury,fiveparticipantshadportsiteinfectionandthreeparticipantshadportsinustractfor- 12.08 0.001 mation. In the study done by Agarwal M et al. [18], theoverallrateofcomplicationswasseentobe3.1% in the TLH group (11/344) as compared to 11.7% in theTAHgroup(30/256),withthebulkofcomplications requiringconservativemanagement.TherateofpostoperativeurinarytractinfectioninTLHwasalmostnil comparedtoTAH,indicatingTLHtobesafeandlessinvasive,thusprotectingagainsthospital-acquiredinfections.Healthcare-associatedUTIs(HAUTIs)represent thelargestsubtypeamongallhealthcare-associated infections. TheprevalenceofHAUTIsassessedinregionalstudiesrangesfrom12.9%intheUSand19.6% inEuropetoupto24%indevelopingcountries[19]. InthestudydonebyAgarwalMetal. [18],onecase eachofbowelinjurywasnotedintheTLHversusTAH group. Bothcaseshaddelayeddiagnosis(2–3days), thussubjectingthepatienttocolostomywithprimary repair.

Limitations

Thestudy’ssingle-centerdesignandrelativelysmall samplesizemaylimitthegeneralizabilityofthefindings.Futureresearchinvolvinglarger,multicentertrialsisnecessarytovalidatetheseresultsandexplore long-termoutcomes.

Conclusion

Totallaparoscopichysterectomy(TLH)offerssignificantadvantagesovertotalabdominalhysterectomy (TAH)formanagingbenigngynecologicalconditions. This study confirms that TLH improves surgical outcomes,enhancesqualityoflife,andfacilitatesfaster recovery.

RAND36components Group Mean Fvalue P.Value

Physicalfunctioning Rolelimitationsdueto TLH 86.683 20.7193 emotionalproblems TAH 40.017 43.0290 Energy/fatigue

Emotionalwell-being

Pain

Socialfunctioning

Generalhealth

Healthchange

RAND36

Complications TAH TLH

Uretericinjury 1 Bladderinjury 0 Anaesthesiaproblems 0 Bloodloss >1000ml 0 Hematoma 1rectussheathhematoma 0 Hematomaneedingsurgery 0 Pulmonaryembolism 0 Infectionorfever 5fever 5portsiteinfection Vaultproblems 0

Others

References

  1. GarryR.Healtheconomicsofhysterectomy. Best Practice and Research. Clinical Obstetrics and Gynaecology.2005;19(3):451-65
  2. PaulsRN.Impactofgynecologicalsurgeryonfemalesexualfunction. InternationalJournalof ImpotenceResearch.2010;22(2):105-14
  3. MokateT,WrightC,ManderT.Hysterectomyand sexualfunction. BritishMenopauseSocietyJournal.2016;12(4):153-7
  4. ClaerhoutF,DeprestJ.Laparoscopichysterectomyforbenigndiseases. BestPractResClinObstetGynaecol.2005;19:357-75
  5. AartsJWNieboerTEJohnsonNTavenderEGarryRMolBW. Surgical approach to hysterectomyforbenigngynaecologicaldisease. CochraneDatabaseSystRev.2015:CD003677
  6. MäkinenJ,BrummerT,JalkanenJ,Heikkinen AM,FraserJ,TomásE,etal.Tenyearsofprogress–improvedhysterectomyoutcomesinFinland Std. ∗ Deviation TLH 70.83 20.345.789.378 TAH 65.17 22.685 49.871 <.0001 TLH 61.500 9.4823 8.348.005 TAH 57.900 18.4841 TLH 75.17 7.746 1.650.204 TAH 67.40 9.961 TLH 71.317 10.4308 13.552.001 TAH 59.350 18.8049 TLH 69.650 12.9968 1.341.252 TAH 60.457 17.7138 TLH 71.67 11.321 2.161.147 TAH 58.33 16.100 TLH 77.67 7.739 3.985.051 TAH 73.50 14.393 TLH 15.5 8.83 0.76 0.87 TAH 14.3 7.74 ∗ ∗IndependentTtest Table6. Complicationsobservedinbothgroups 2woundgapingneeding 3portsinustractformation secondarysuturing 1996-2006:Alongitudinalobservationstudy. Br MedJOpen.2013;3(10):28
  7. ReichH,RobertsL.Laparoscopichysterectomy incurrentgynaecologicalpractice. Reviewsin GynaecologicalPractice.2003;3:32-40
  8. GarryR.Towardsevidence-basedhysterectomy. GynaecologicalEndoscopy.1998;7:225-33
  9. JohnsonN,BarlowD,LethabyA,TavenderE,Curr L,GarryR.Methodsofhysterectomy:systematic review and meta-analysis of randomised controlledtrials. BrMedJ.2005;330:1478
  10. ClarkeA,BlackN,RoweP,MottS,HowleK.Indicationsforandoutcomeoftotalabdominalhysterectomyforbenigndisease:Aprospectivecohortstudy. BrJObstetGynaecol.1995;102(8):611- 20
  11. KhanikiM,ShojaieM,TarafdariA.HistopathologicalstudyofhysterectomyoperationsinauniversityclinicinTehranfrom2005to2009. JFamily ReprodHealth.2011;5(2):51-5
  12. MaranaR,BusaccaM,ZupiE,GarceaN,Paparella P,CatalanoGF.Laparoscopicallyassistedvaginal hysterectomyversustotalabdominalhysterectomy: aprospective,randomized,multicenter study. AmJObstetGynecol.1999;180(2):270-5
  13. AartsJWNieboerTEJohnsonNTavenderEGarryRMolBW. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2015;2015(8):CD003677
  14. TakahashiA,UemuraM,KitazawaJ,NakataM, Hayashi Y. Laparoscopic hysterectomy for benignpathologydoesnotyieldmoreperioperative complications than abdominal or vaginal hysterectomies: ourexperienceinintroducing laparoscopichysterectomy. GynecolMinimInvasiveTher.2020;9(4):215-9
  15. BaekJW,GongDS,LeeGH.Acomparativestudy oftotallaparoscopichysterectomy(TLH)andtotalabdominalhysterectomy(TAH). KoreanJObstetGynecol.2005;48(6):1490-6
  16. SutasanasuangS. Laparoscopic hysterectomy versus total abdominal hysterectomy: A retrospectivecomparativestudy. JMedAssocThail. 2011;94(1):8-16
  17. NagarOS. A comparative study between total laparoscopic hysterectomy and total abdominal hysterectomy for benign uterine conditions. IntJReprodContraceptObstetGynecol. 2023;12(12):3571-7
  18. AgarwalMSinhaSSinghSHaripriyaHRoyI. Surgical morbidity of laparoscopic hysterectomyversusabdominalhysterectomy: Aretrospectiveoverview. GynecolMinimInvasiveTher. 2023;12(3):161-5
  19. TandogduZ,WagenlehnerFM.Globalepidemiologyofurinarytractinfections. CurrOpinInfect Dis.2016;29:73-9